Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are serial dexamethasone suppression tests useful in electroconvulsive therapy?

W Coryell

    Journal of Affective Disorders
    |January 1, 1986
    PubMed
    Summary

    The dexamethasone suppression test (DST) did not predict recovery or relapse in patients undergoing electroconvulsive therapy (ECT). Changes in DST status during ECT did not correlate with patient improvement, suggesting complex effects on the hypothalamic-pituitary-adrenal axis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants.

    Molecular psychiatry·2012
    Same author

    Genome-wide association study of recurrent early-onset major depressive disorder.

    Molecular psychiatry·2010
    Same author

    Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.

    Molecular psychiatry·2009
    Same author

    Genome-wide association study of bipolar disorder in European American and African American individuals.

    Molecular psychiatry·2009
    Same author

    Age transitions in the course of bipolar I disorder.

    Psychological medicine·2009
    Same author

    Does major depressive disorder change with age?

    Psychological medicine·2009

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Endocrinology

    Background:

    • The dexamethasone suppression test (DST) is used to diagnose conditions like Cushing's syndrome and depression.
    • Previous research suggests DST may predict treatment outcomes in patients receiving antidepressants.
    • However, findings for patients undergoing electroconvulsive therapy (ECT) have been inconsistent.

    Purpose of the Study:

    • To investigate the predictive value of DST results for recovery or relapse in patients undergoing ECT.
    • To explore the relationship between DST changes and clinical improvement during ECT.

    Main Methods:

    • 30 patients who were nonsuppressors before ECT were monitored.
    • Hamilton rating scale scores (measuring depression severity) and DST results were charted weekly during ECT.

    Related Experiment Videos

  • Correlation between DST changes and clinical improvement was analyzed.

    • Main Results:

    • Week-to-week changes in depression severity roughly corresponded to expected DST changes.
    • However, shifts in DST results showed no apparent predictive value for recovery or relapse.
    • Interestingly, transitions to nonsuppressor status were more frequently followed by improvement than transitions to suppressor status.

    Conclusions:

    • The DST's predictive utility for ECT outcomes appears limited.
    • ECT may exert complex, potentially opposing, direct and indirect effects on the hypothalamic-pituitary-adrenal axis.
    • Further research is needed to understand these neuroendocrine interactions during ECT.